Introduction of the Genomics and Precision Medicine special issue

     Bladder: Genomics and Precision Medicine may include: investigations of the molecular basis underlying diseases such as cancer of the bladder and its neighboring organs. The scientific content would include genetic and genomic association studies and functional interpretation, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics as well as integration of electronic health record data or patient-derived data with any of the aforementioned approaches; systems biology approaches to the diagnosis and management of diseases of the bladder and urinary tract covering by urothelium; and novel applications of precision medicine.


Guest Editors-in-Chief Profile

Gong-Hong Wei

      Dr. Gong-Hong Wei is currently a distinguished professor at Shanghai Medical College, Fudan University. Dr. Wei graduated from his PhD study in Peking Union Medical College, Beijing, China. After postdoctoral training at the University of Helsinki, Finland, Dr. Wei joined in the University of Oulu as a faculty member and then a full professor, heading a functional and systems genomics laboratory for cancer research. Dr. Wei’s laboratory focuses on the epigenetic regulation of gene expression network during cancer susceptibility, initiation and progression to metastasis, and the identification of biomarkers for cancer risk prediction and stratification. Over the past several years, Dr. Wei’s team performed systems functional interpretation of noncoding genomic variations in association with cancer discovered by genome-wide association studies and investigated cancer driver genes revealed by whole genome sequencing, and published several senior-authored papers in the international top journals such as Cell and Nature Genetics. Dr. Wei received a prestigious Academy of Finland Research Fellow post and title of docent (honorary title granted for lifetime) in molecular genetics in 2014, and was shortly promoted as a full professor, and recently joined Shanghai Medical College of Fudan University as a distinguished professor. Dr. Wei won the Medix Prize 2015 and 2019, and the Discovery of the Year 2014, 2016 and 2018 at Biocenter Oulu, and served as a reviewer for over 40 different journals, including Nature Genetics, Nature Communications, Genome Research, Cell Research, Cell Discovery, Science Bulletin and so forth.

Song Wu

       Dr. Song Wu is currently a distinguished professor at Shenzhen University, deputy director of the Department of Medicine, president of South China Hospital, winner of the Guangdong Youth Science and Technology Award, Shenzhen Youth Science and Technology Award, the leading talent of Guangdong Science and Technology Innovation, and winner of the National May Day Labor Medal, mainly engaged in medical research such as the mechanism of urinary diseases, clinical diagnosis and treatment, and the construction of intelligent diagnosis system. He leads the key project of the National Natural Science Foundation of China (Department of Informatics), the Outstanding Youth Fund of the National Natural Science Foundation of China (Ministry of Medicine), the Ministry of Science and Technology Key Research and Development Special Project (Young Scientist Program), and other funds. As the first author (including co-one) and corresponding author (including co-author), he published 82 SCI papers in journals such as EUR UROL, ICASSP, EUR RADIOL, NAT GENET, ADV MATER, and CELL RES. Among them, 54 papers were published as the final communication or independent communication, 36 papers in JCR Region I, 21 papers in Region I of the Chinese Academy of Sciences, 16 papers IF> 10.0, 6 papers IF> 20.0, 4 papers IF>30.0, the total number of citations of Google Scholar is "5501", the H-index is "34", and the international level of professional fields is in the top "0.57%". He has transferred 4 patents, achieved 2 product development and marketing, obtained 2 national medical device certificates, and provided nearly 10 million screenings for non-invasive early screening products transformed into the urine. He has published 396 articles related to health management, with a cumulative total of 1.01 million views. He is the Chief Editor of Introduction to Precision Medicine and Saying Goodbye to Urinary Tract Stones. He serves as the editorial board member of the classic Chinese surgical treatise Wu Jieping Urology and Guidelines for the Diagnosis and Treatment of Bladder Cancer.


Accepted types of manuscripts:

1. Research review: An in-depth summary of representative research results in the field in the last 5 to 10 years, with a comprehensive review of the scientific significance, current research status and development trends in the field. The content of the review should be based on or directly related to the author's professional research.

2. Research  papers:  Report the  latest  scientific research results with  theoretical, innovative and important scientific value, such as basic research and core technology research in the field.

3. Mini reviews: offer a brief and focused summary of recent insights or advances in genomics and precision medicine.

4. Perspectives: expert views and opinions on issues of importance to genomics or precision medicine.

5. Research highlights: short commentaries on one or more recently published journal articles that report novel and significant findings and interest the readers. Research highlights should be commissioned from leading experts in the field of genomics and precision medicine.


How to SUBMIT your paper:

Please click "Make a Submission" and choose "2023 SI: Genomics and Precision Medicine" in the article type section.